BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37241066)

  • 21. Prognostic Significance of ARID1A Expression Patterns Varies with Molecular Subtype in Advanced Gastric Cancer.
    Kim JY; Park CK; Noh S; Cheong JH; Noh SH; Kim H
    Gut Liver; 2023 Sep; 17(5):753-765. PubMed ID: 36789575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Behavior and Treatment Response of Epstein-Barr Virus-Positive Metastatic Gastric Cancer: Implications for the Development of Future Trials.
    Corallo S; Fucà G; Morano F; Salati M; Spallanzani A; Gloghini A; Volpi CC; Trupia DV; Lobefaro R; Guarini V; Milione M; Cattaneo L; Antista M; Prisciandaro M; Raimondi A; Sposito C; Mazzaferro V; de Braud F; Pietrantonio F; Di Bartolomeo M
    Oncologist; 2020 Sep; 25(9):780-786. PubMed ID: 32272500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus in gastric carcinomas with lymphoid stroma.
    Chang MS; Kim WH; Kim CW; Kim YI
    Histopathology; 2000 Oct; 37(4):309-15. PubMed ID: 11012737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
    Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
    Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma.
    Song HJ; Srivastava A; Lee J; Kim YS; Kim KM; Ki Kang W; Kim M; Kim S; Park CK; Kim S
    Gastroenterology; 2010 Jul; 139(1):84-92.e2. PubMed ID: 20398662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Landscape of KRAS, BRAF, and PIK3CA Mutations and Clinical Features of EBV-Associated and Microsatellite Unstable Gastric Cancer].
    Danishevich AM; Pospehova NI; Stroganova AM; Golovina DA; Nikulin MP; Kalinin AE; Nikolaev SE; Stilidi IS; Lyubchenko LN
    Mol Biol (Mosk); 2023; 57(1):71-84. PubMed ID: 36976740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very low risk of lymph node metastasis in Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma.
    Cheng Y; Zhou X; Xu K; Huang J; Huang Q
    BMC Gastroenterol; 2020 Aug; 20(1):273. PubMed ID: 32807085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of circulating Epstein-Barr virus DNA in pulmonary lymphoepithelioma-like carcinoma: A meta-analysis and validation study.
    Wei X; Wei Z; Zheng G; Xie T; Huo Z; Huang Y; Chen X; Bai J
    J Med Virol; 2023 Jan; 95(1):e28349. PubMed ID: 36428250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent expression of thymidine phosphorylase in Epstein-Barr virus-associated gastric carcinoma of diffuse type.
    Koriyama C; Akiba S; Shimaoka S; Itoh T; Akiyama S; Eizuru Y
    Anticancer Res; 2010 Jun; 30(6):2431-7. PubMed ID: 20651404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Epstein-Barr Virus (EBV) miRNA biomarkers for survival outcome in EBV-associated epithelial malignancies: Systematic review and meta-analysis.
    Abusalah MAH; Irekeola AA; Hanim Shueb R; Jarrar M; Yean Yean C
    PLoS One; 2022; 17(4):e0266893. PubMed ID: 35436288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus-associated gastric carcinoma among patients with pernicious anemia.
    Boysen T; Friborg J; Stribolt K; Hamilton-Dutoit S; Goertz S; Wohlfahrt J; Melbye M
    Int J Cancer; 2011 Dec; 129(11):2756-60. PubMed ID: 21225628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular profile of gastric adenocarcinoma, relevant epidemiological factors - Systematic review and meta-analysis relating sex with Epstein-Barr virus and unstable microsatellites subtypes.
    Santos GOD; Nunes WA; Júnior WF; Botega LG; Roehe AV
    Asia Pac J Clin Oncol; 2024 Feb; 20(1):109-118. PubMed ID: 37932908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDX-1/CDX-2 Expression Is a Favorable Prognostic Factor in Epstein-Barr Virus-Negative, Mismatch Repair-Proficient Advanced Gastric Cancers.
    Kim K; Noh S; Cheong JH; Kim H
    Gut Liver; 2021 Sep; 15(5):694-704. PubMed ID: 34312322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers.
    Derks S; Liao X; Chiaravalli AM; Xu X; Camargo MC; Solcia E; Sessa F; Fleitas T; Freeman GJ; Rodig SJ; Rabkin CS; Bass AJ
    Oncotarget; 2016 May; 7(22):32925-32. PubMed ID: 27147580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histology-specific gender, age and tumor-location distributions of Epstein-Barr virus-associated gastric carcinoma in Japan.
    Koriyama C; Akiba S; Corvalan A; Carrascal E; Itoh T; Herrera-Goepfert R; Eizuru Y; Tokunaga M
    Oncol Rep; 2004 Sep; 12(3):543-7. PubMed ID: 15289835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma.
    Kaizaki Y; Hosokawa O; Sakurai S; Fukayama M
    J Gastroenterol; 2005 Jun; 40(6):570-7. PubMed ID: 16007390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials.
    Biesma HD; Soeratram TTD; Sikorska K; Caspers IA; van Essen HF; Egthuijsen JMP; Mookhoek A; van Laarhoven HWM; van Berge Henegouwen MI; Nordsmark M; van der Peet DL; Warmerdam FARM; Geenen MM; Loosveld OJL; Portielje JEA; Los M; Heideman DAM; Meershoek-Klein Kranenbarg E; Hartgrink HH; van Sandick J; Verheij M; van de Velde CJH; Cats A; Ylstra B; van Grieken NCT
    Gastric Cancer; 2022 May; 25(3):640-651. PubMed ID: 35129727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability.
    Abe H; Maeda D; Hino R; Otake Y; Isogai M; Ushiku AS; Matsusaka K; Kunita A; Ushiku T; Uozaki H; Tateishi Y; Hishima T; Iwasaki Y; Ishikawa S; Fukayama M
    Virchows Arch; 2012 Oct; 461(4):367-77. PubMed ID: 22915242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
    Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
    World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.
    Min BH; Tae CH; Ahn SM; Kang SY; Woo SY; Kim S; Kim KM
    Gastric Cancer; 2016 Jul; 19(3):852-9. PubMed ID: 26265391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.